Dysbiotic alteration in the fecal microbiota of patients with polycystic ovary syndrome/Experiment 1

From BugSigDB


Reviewed Marked as Reviewed by KateRasheed on 2025-7-25

Curated date: 2025/07/04

Curator: Victoria

Revision editor(s): Victoria

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Polycystic ovary syndrome Cystic disease of ovaries,hyperandrogenemia,Multicystic ovaries,multicystic ovaries,Ovarian Degeneration, Sclerocystic,Ovarian Syndrome, Polycystic,Ovarian Syndromes, Polycystic,Ovaries, Sclerocystic,Ovary Syndrome, Polycystic,Ovary, Sclerocystic,PCO - Polycystic ovaries,Pco1,PCOD - Polycystic ovarian disease,PCOS,Pcos,PCOS - Polycystic ovarian syndrome,PCOS1,Polycystic ovarian disease,polycystic ovarian disease,Polycystic ovarian syndrome,Polycystic ovaries,polycystic ovaries,Polycystic ovaries (disorder),polycystic ovary,polycystic ovary syndrome,polycystic ovary syndrome 1,Sclerocystic Ovarian Degeneration,Sclerocystic Ovaries,Sclerocystic Ovary,Sclerocystic Ovary Syndrome,Stein Leventhal Syndrome,Stein-Leventhal synd.,Stein-Leventhal Syndrome,Stein-Leventhal syndrome,Syndrome, Polycystic Ovary,Syndrome, Stein-Leventhal,Polycystic ovary syndrome
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Healthy control group
Group 1 name Corresponds to the case (exposed) group for case-control studies
Polycystic ovary syndrome group (PCOS)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
This group consists of women who were diagnosed with polycystic ovary syndrome according to the 2003 Rotterdam criteria.
Group 0 sample size Number of subjects in the control (unexposed) group
17
Group 1 sample size Number of subjects in the case (exposed) group
17

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
Mann-Whitney (Wilcoxon)
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes
Matched on Factors on which subjects have been matched on in a case-control study
age

Alpha Diversity

Pielou Quantifies how equal the community is numerically
decreased
Shannon Estimator of species richness and species evenness: more weight on species richness
decreased
Chao1 Abundance-based estimator of species richness
decreased
Simpson Estimator of species richness and species evenness: more weight on species evenness
decreased
Richness Number of species
decreased

Signature 1

Reviewed Marked as Reviewed by KateRasheed on 2025-7-25

Curated date: 2025/07/04

Curator: Victoria

Revision editor(s): Victoria

Source: Figure 3d, 4b and Result text.

Description: Comparison of intestinal microbiota abundance of PCOS patients and healthy group at the phylum and family level (Mann-Whitney U-test, n = 17).

Abundance in Group 1: increased abundance in Polycystic ovary syndrome group (PCOS)

NCBI Quality ControlLinks
Actinomycetota
Aerococcaceae
Bifidobacteriaceae
Carnobacteriaceae
Rhodocyclaceae
Gemellaceae

Revision editor(s): Victoria

Signature 2

Reviewed Marked as Reviewed by KateRasheed on 2025-7-25

Curated date: 2025/07/04

Curator: Victoria

Revision editor(s): Victoria

Source: Figure 3d, 4b, 5b and Result text.

Description: Comparison of intestinal microbiota abundance of PCOS patients and healthy group at the phylum, family, and genus level (Mann-Whitney U-test, n = 17).

Abundance in Group 1: decreased abundance in Polycystic ovary syndrome group (PCOS)

NCBI Quality ControlLinks
Abiotrophia
Acidaminococcaceae
Alistipes
Anaeromassilibacillus
Bacillota
Bacteroidaceae
Bacteroides
Bacteroidota
Barnesiella
Barnesiellaceae
Butyricicoccaceae
Butyricicoccus
Butyricimonas
Christensenellaceae
Clostridiaceae
Eubacteriaceae
Eubacteriales Family IV. Incertae Sedis
Eubacterium
Eubacterium coprostanoligenes
Eubacterium ventriosum
Flavonifractor
Gracilibacteraceae
Intestinimonas
Lachnoclostridium
Lachnospira
Lachnospira eligens
Lachnospiraceae
Marinifilaceae
Odoribacter
Oscillibacter
Oscillospiraceae
Oxalobacteraceae
Parabacteroides
Paraprevotella
Peptococcaceae
Prevotellaceae
Rikenellaceae
Roseburia
Ruminococcaceae bacterium UCG-005
Sutterella
Tannerellaceae
unclassified Atopobiaceae
unclassified Bacillota
unclassified Bacteroidota
unclassified Christensenellaceae
unclassified Lachnospiraceae
unclassified Peptococcaceae
UCG-010UCG-010
unclassified Clostridia UCG-014unclassified Clostridia UCG-014
unclassified DTU014unclassified DTU014
UCG-002UCG-002
unclassified Eubacterium coprostanoligenesunclassified Eubacterium coprostanoligenes
UCG-003UCG-003
NK4A214 groupNK4A214 group

Revision editor(s): Victoria